Literature DB >> 20534391

Standardisation and outcomes audit: a step forward in surgical oncology.

S González-Moreno.   

Abstract

Mesh：

Year:  2010        PMID： 20534391     DOI： 10.1007/s12094-010-0523-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  8 in total

Review 1.  The surgeon as a prognostic factor in the surgical treatment of rectal cancer.

Authors:  Antonio Di Cataldo; Beniamino Scilletta; Rosalia Latino; Aldo Cocuzza; Giovanni Li Destri
Journal:  Surg Oncol       Date:  2007-11-26       Impact factor: 3.279

2.  Total mesorectal excision. The new European gold standard.

Authors:  R J Heald
Journal:  G Chir       Date:  1998 Jun-Jul

3.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

4.  Hospital volume and late survival after cancer surgery.

Authors:  John D Birkmeyer; Yating Sun; Sandra L Wong; Therese A Stukel
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

5.  A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit.

Authors:  Arne Wibe; Bjørn Møller; Jarle Norstein; Erik Carlsen; Johan N Wiig; Richard J Heald; Frøydis Langmark; Helge E Myrvold; Odd Søreide
Journal:  Dis Colon Rectum       Date:  2002-07       Impact factor: 4.585

6.  Centralization of esophageal cancer surgery: does it improve clinical outcome?

Authors:  M W J M Wouters; H E Karim-Kos; S le Cessie; B P L Wijnhoven; L P S Stassen; W H Steup; H W Tilanus; R A E M Tollenaar
Journal:  Ann Surg Oncol       Date:  2009-04-16       Impact factor: 5.344

7.  Treatment of gastric adenocarcinoma may differ among hospital types in the United States, a report from theNational Cancer Data Base.

Authors:  Kaye M Reid-Lombardo; Greer Gay; Lina Patel-Parekh; Jaffer A Ajani; John H Donohue
Journal:  J Gastrointest Surg       Date:  2007-03-14       Impact factor: 3.452

8.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.